首页> 中文期刊>中华肝胆外科杂志 >肝癌肝移植受者一年内致死性复发风险因素分析

肝癌肝移植受者一年内致死性复发风险因素分析

摘要

目的 分析影响肝细胞癌肝移植术后一年内因转移复发死亡的临床病理学风险因素.方法 回顾性分析2002年4月至2005年4月间武警总医院器官移植研究所303例肝细胞肝癌行肝移植病人一年内因转移复发而死亡受者(致死性复发组)的临床病理资料,与未复发或复发但未在一年内死亡的受者(对照组)比较,采用logistic回归分析探讨l临床病理学风险因素对一年生存率的影响.结果 303例病人中有48例在一年内因转移复发死亡(死亡率15.84%),多因素分析显示肿瘤血管浸润、直径≥6.5 cm和移植术前血清AFP≥1000 μg/L是致死性复发的独立风险因素.同时具备上述三种风险因素受者一年内致死性复发85.71%,同时具有2项以上风险者37.84%,具备其中一项风险因素者13.64%,不具备三种中任何一种风险因素者致死性复发发生率为6.71%.结论 三种导致肝细胞肝癌病人在手术后一年内因肿瘤复发转移死亡的主要危险因素是肿瘤血管浸润、直径≥6.5 cm和移植术前血清AFP≥1000 μg/L.同时具备2个或2个以上的致死性复发的临床病理学风险病人不适宜作为肝移植的适应证.%Objective To investigate the clinicopathological risk factors for fatal recurrence of hepatocellular carcinoma(HCC)in orthotopic liver transplant(OLT)recipients died within one year.Methods The clinical data of 303 patients receiving OLT in our hospital from April 2002 tO April 2005 were retrospectively analyzed.Forty-eight of these patients who demonstrated diffuse intra-he-patio or multiple systemic recurrent lesions and died within 1 year after surgery were furthere investi-gated.The remaining patients were designated as the control group.The 2 groups were compared for clinicopathologic risk factors by logistic regression analysis. Results Among the 303 patients,48 were enrolled in the ratal recurrence group(15.84%).Multivariate analysis showed that presence of vascular invasion,tumor size greater than 6.5 cm,and pre-operative serum alpha-fetoprotein(AFP) level greater than 1000 μg/L were the risk factors in the fatal recurrence group.A percentage of 85.71%of the patients who had all the three risk factors.37.84% of those who had two risk factors,13.64%of those who had one risk factors,and 6.71%of those who had none risk factors died be-cause of recurrence within 1 year after transplantation.Conclusion Three distinct risk factors attribu-ting to fatal recurrence of liver transplant recipients for HCC are vascular invasion,tumor size ≥6.5 cm,and pre-operative serum AFP level≥1000 μg/L.The high risk HcC patients with two or more risk factors should not be the candidates for liver transDlantation.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号